Medical Developments International Limited

Research Medical Developments International Limited (MVP.AX) on Bullrun: market cap AUD 46.19M, P/E 41.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is AUD 46.19M; P/E is 41.0.

Peer valuation comparison

Latest P/E is 41x versus a Healthcare sector median of 21.74x (88.6% above).

Latest P/E is 41x versus a Australia median of 14.68x (179.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026n/an/an/an/a0.01n/an/an/a
FY2025AUD 39.06MAUD 94.00K-AUD 1.08M75.3%0AUD 17.84MAUD 1.99MAUD 55.10M
FY2024AUD 33.15M-AUD 40.99M-AUD 13.95M73.5%-0.46AUD 9.74MAUD 2.29MAUD 45.73M
FY2023AUD 32.17M-AUD 5.61M-AUD 24.73M68.5%-0.06AUD 24.66MAUD 2.56MAUD 81.32M
FY2022AUD 22.37M-AUD 12.41M-AUD 15.99M69.9%n/aAUD 20.40MAUD 2.81MAUD 57.30M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-17AUD 46.19M41.0n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 AUD.

About Medical Developments International Limited

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Medical Developments International Limited's market cap?

Medical Developments International Limited's market capitalization is AUD 46.19M.

What is Medical Developments International Limited's P/E ratio?

Medical Developments International Limited's price-to-earnings (P/E) ratio is 41.0.

What does Medical Developments International Limited do?

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures.